≋ THREE SHORE AI

HEALTH / REGULATORY INTELLIGENCE

PLATO

A product history.
A clearer path
to the evidence.

Product Lifecycle Analytics for Tobacco Oversight connects fragmented regulatory information into a traceable, product-centered reviewer experience.

Prototype accelerator · Public-data foundation · Human review

Regulatory scientist reviewing tobacco testing samples and technical evidence in a compliance laboratory
Regulatory review brings product records, supporting evidence, and human judgment together.

THE REGULATORY CHALLENGE

Follow the product.
Preserve the context.

Product names, identifiers, and submission events can change over time. PLATO provides a product-first design for connecting original applications, amendments, resubmissions, documents, and decisions.

Bring the supporting passage, proposed relationship, and reviewer decision together so analysts can understand both what changed and why an association was proposed.

SIX CONNECTED CAPABILITIES

Built around reviewable evidence.

Client-specific workflows are proposed for configuration and evaluation using authorized data.

01

Product data architecture

Organize product attributes, submissions, documents, parties, reviews, and master file references around a persistent product identity.

02

Document intelligence

Configure document classification and attribute extraction with values, units, confidence, and source locations.

03

Cross-submission linking

Use explicit identifiers and documented references first. Present attribute-based associations with rationale for reviewer approval.

04

Lifecycle and change analysis

Reconstruct product histories and compare versions while distinguishing event, document, and effective dates.

05

Source traceability

Retain page and section references, OCR and redaction flags, model and prompt versions, and reviewer decisions.

06

Integration readiness

Prepare interface specifications, schemas, versioned configurations, dependencies, and reproducibility guidance.

TOBACCO REGULATIONS & ANALYTICS

Regulatory context.
Connected product evidence.

PLATO’s proposed information model connects tobacco submission pathways with product histories, source evidence, and human review. These graphics illustrate the design rather than a live application.

PMTA, SE, and EX REQ records connect to a product record with submission context, source evidence, and reviewer decisions.
Track pathway context alongside the supporting record. FDA describes the PMTA, SE, and EX REQ pathways; the PLATO information model shown here is conceptual.

PMTA

Premarket Tobacco Product Application: organize application records and supporting evidence.

SE

Substantial Equivalence: connect comparison records and product characteristics.

EX REQ

Exemption from Substantial Equivalence: retain request context and associated records.

TOBACCO PRODUCT LIFECYCLES

Understand change without losing the source.

A product anchor gives reviewers continuity as submission identifiers and records change. Compare formulation or design attributes, retain source passages, and keep event, document, and effective dates distinct.

Illustrative application, amendment, resubmission, review, and outcome records connected to one product anchor.
Illustrative record sequence. Actual records, chronology, and outcomes depend on the source and applicable pathway.

EVIDENCE ANALYTICS

Make uncertainty visible and actionable.

Explore source coverage, version differences, and review workload. Tobacco-specific examples include nicotine concentration and units, ingredient and formulation references, harmful and potentially harmful constituent (HPHC) test-result references, and product design attributes.

Synthetic tobacco evidence matrix: source-linked nicotine values support comparison; redacted formulation retains access limits; unreadable test references require manual review; absent design data is flagged.
Qualitative synthetic examples illustrate proposed review behavior. No live portfolio, compliance rating, or measured performance is displayed.

Coverage

Distinguish source-linked attributes from redacted, unreadable, missing, and not-applicable values.

Change

Compare source-backed versions before accepting a proposed change or relationship.

Workload

Route uncertain findings to reviewers and retain their decisions and reasons.

PLATO IN VIEW

Source evidence beside extracted attributes.

The synthetic reviewer workspace illustrates classification, highlighted source passages, version comparison, explicit absence reasons, and reviewer confirmation.

Synthetic PLATO reviewer screen with source page, extracted attributes, version differences, and confirm, correct, and flag actions.

HUMAN CONTROL

Propose. Explain. Review.

Reviewers confirm, correct, reject, defer, or flag proposed outputs. Decisions and reasons form an audit trail. Missing values retain a reason such as redacted, unreadable, missing, or not applicable.

Classification, extraction, linking, and comparison flow into human evidence validation; source, context, and provenance accompany outputs.
Conceptual workflow illustrating proposed client behavior. Select the image for a full-size view.

REPRESENTATIVE USE CASES

Three ways to support the reviewer.

01

Reconstruct a product history

Bring related submissions, amendments, and decisions into a longitudinal view.

02

Verify product attributes

Compare extracted values against source passages and record corrections or absence reasons.

03

Assess a relationship or change

Inspect link rationale and version differences before accepting a proposed association or change alert.

FROM PROTOTYPE TO EVALUATED READINESS

Start with evidence. Validate in context.

PLATO’s evidence base consists of public FDA data profiling and a synthetic demonstration. It makes no regulatory determinations about real products and does not establish production deployment, measured accuracy, or production readiness.

Client work depends on representative samples, approved tools and workspaces, authorized access, reviewer participation, and agreed evaluation thresholds. Confidential commercial information and master file references retain their access boundaries.

Explore our Health & Regulatory Intelligence services

START WITH YOUR MISSION

Bring your regulatory
review challenge into focus.

Define the sources, reviewer needs, and outcomes for an evaluated pilot.

Discuss a PLATO demonstration